1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Kuwait Pharmaceuticals and Healthcare Report Q3 2016

Kuwait Pharmaceuticals and Healthcare Report Q3 2016

  • May 2016
  • -
  • Business Monitor International
  • -
  • 87 pages

Includes 3 FREE quarterly updates

BMI View: With the recent oil strike representing a harbinger of significant political and economicturbulence ahead, the stability of its health and pharmaceutical sectors will depend on Kuwait's integrationwith neighbouring Gulf states and international partners.

Headline Expenditure Projections

- Pharmaceuticals: From KWD300mn (USD997mn) in 2015 to KWD453mn (USD1.48bn) in 2016;+51.1% in local currency terms and +48.2% in US dollar terms. Forecast revised upward from Q216.

- Healthcare: From KWD1.67bn (USD5.54bn) in 2015 to KWD1.79bn (USD5.83bn) in 2016; +7.2% inlocal currency terms and +5.2% in US dollar terms. Forecast in line with Q216.

Table Of Contents

Kuwait Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Kuwait 2014-2020) 7
SWOT 9
Industry Forecast 12
Pharmaceutical Market Forecast 12
Table: Pharmaceutical Sales, Historical Data And Forecasts (Kuwait 2012-2020) 13
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Kuwait 2012-2020) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Kuwait 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Kuwait 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Kuwait 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Kuwait 2012-2020) 22
Generic Medicines Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Kuwait 2012-2020) 24
OTC Medicine Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Kuwait 2012-2020) 26
Pharmaceutical Trade Forecast 27
Table: Pharmaceutical Trade Data And Forecasts (Kuwait 2014-2020) 29
Table: Pharmaceutical Trade Data And Forecasts local currency (Kuwait 2014-2020) 29
Industry Risk Reward Index 30
Middle East and Africa Risk/Reward Index - Q3 2016 30
Kuwait Risk/Reward Index 38
Rewards 38
Risks 39
Regulatory Review 40
Intellectual Property Issues 42
Pricing Regime 43
Reimbursement Regime 45
Market Overview 50
Healthcare Sector 50
Clinical Trials 57
Epidemiology 57
Competitive Landscape 62
Research-Based Industry 62
Table: Multinational Company Activity 63
Pharmaceutical Distribution 64
Pharmaceutical Retail Sector 64
Company Profile 66
Advanced Technology Company 66
Bader Sultan and Bros 69
Kuwait-Saudi Pharmaceutical Industries (KSP) 72
Safwan Trading And Contracting Company 74
Demographic Forecast 76
Table: Population Headline Indicators (Kuwait 1990-2025) 77
Table: Key Population Ratios (Kuwait 1990-2025) 77
Table: Urban/Rural Population and Life Expectancy (Kuwait 1990-2025) 78
Table: Population By Age Group (Kuwait 1990-2025) 78
Table: Population By Age Group % (Kuwait 1990-2025) 79
Glossary 81
Methodology 83
Pharmaceutical Expenditure Forecast Model 83
Healthcare Expenditure Forecast Model 83
Notes On Methodology 84
Risk/Reward Index Methodology 85
Index Overview 86
Table: Pharmaceutical Risk/Reward Index Indicators 86
Indicator Weightings 87

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.